Phar­ma mar­ket­ing 2022: More dig­i­tal shifts for reps, ads and drug launch­es, plus rep­u­ta­tion and the meta­verse

Whether you call it the new nor­mal, the next nor­mal or just a ma­jor shift, phar­ma mar­ket­ing will nev­er be the same thanks to the Covid-19 pan­dem­ic.

From the ac­cel­er­a­tion of dig­i­tal strate­gies and com­mu­ni­ca­tion to rep­u­ta­tion boosts be­yond what any­one could have imag­ined, phar­ma and biotech mar­ket­ing is on a per­ma­nent new path. And while some of that path is still un­der con­struc­tion and will con­tin­ue for the next sev­er­al years, ex­perts pre­dict some de­fined trends for 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER